Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine versus solifenacin for overactive bladder symptoms
IRCT2016101727998N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tolterodine and solifenacin in overactive bladder (OAB) and urinary incontinence (UI) (2 arms), sponsored by Tehran University of Medical Sciences. Started Apr 2015; status: completed.
02
Drugs
tolterodinesolifenacin
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on IRCT2016101727998N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016101727998N3.